Variant report
Variant | esv1845396 |
---|---|
Chromosome Location | chr3:145635631-145645958 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558820687 | chr3:145643430-145643431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577493403 | chr3:145643433-145643434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375736526 | chr3:145643437-145643438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112709079 | chr3:145643501-145643502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369879779 | chr3:145643514-145643515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200185879 | chr3:145643611-145643612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371249840 | chr3:145643644-145643645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544773688 | chr3:145643646-145643647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560951908 | chr3:145643650-145643651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556494051 | chr3:145643676-145643677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114590419 | chr3:145643686-145643687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185086128 | chr3:145643829-145643830 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560480986 | chr3:145643847-145643848 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6762748 | chr3:145643853-145643854 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs546268249 | chr3:145643871-145643872 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144207252 | chr3:145643875-145643876 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1398780 | chr3:145643928-145643929 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs146536363 | chr3:145643931-145643932 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190067947 | chr3:145643940-145643941 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528915497 | chr3:145643960-145643961 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369929948 | chr3:145644007-145644008 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181143292 | chr3:145644013-145644014 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs960451 | chr3:145644014-145644015 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs141002264 | chr3:145644041-145644042 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551122704 | chr3:145644062-145644063 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571088023 | chr3:145644121-145644122 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 21509527 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:145643400-145644200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr3:145643800-145644200 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr3:145643800-145644200 | Active TSS | Aorta | Aorta |